Search Results

Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.

• Authors : Laucella; Segura; Riarte

• Source: Clinical & Experimental Immunology. Dec99, Vol. 118 Issue 3, p423-427. 5p. 5 Graphs.

Record details

In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypanosoma cruzi population.

• Authors : Murta; Ropert; Alves

• Source: Parasite Immunology. Oct99, Vol. 21 Issue 10, p535-544. 10p.

Record details

Reactivation of chronic Chagas’ disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.

• Authors : Altclas, J.; Sinagra, A.; Jaimovich, G.

• Source: Transplant Infectious Disease. Jun99, Vol. 1 Issue 2, p135. 3p.

Record details

Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.

• Authors : Revelli; LE. Page; Piaggio

• Source: Clinical & Experimental Immunology. Nov99, Vol. 118 Issue 2. 1 Black and White Photograph, 4 Graphs.

Record details

International comparator products for bioquivalence testing.

• Source: WHO Drug Information. 1999, Vol. 13 Issue 3, p158. 5p.

Record details